<DOC>
	<DOCNO>NCT01434524</DOCNO>
	<brief_summary>The long-term outcome branched-chain amino acid ( BCAA ) administration patient undergo hepatic resection remain unclear . The aim study assess impact oral supplementation BCAA prevention development liver tumorigenesis patient undergo liver resection .</brief_summary>
	<brief_title>Prevention Development Liver Tumorigenesis Oral Supplementation Branched-chain Amino Acids</brief_title>
	<detailed_description>This study might demonstrate tendency improvement cumulative tumor recurrence rate hepatectomy liver neoplasm Livact group compare Control Group . The investigator believe BCAA seem remarkable benefit liver resection , especially reduction recurrence liver cancer . This treatment regimen potential offer benefit clinical use selectively , especially patient chronic liver disease .</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Carcinogenesis</mesh_term>
	<mesh_term>Cell Transformation , Neoplastic</mesh_term>
	<criteria>These patient schedule elective liver resection treat hepatocellular carcinoma adenocarcinoma liver . bodyweight loss great 10 % 6 month prior surgery , presence distant metastasis , serious impairment organ function due respiratory , renal , heart disease .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>